Abstract

BackgroundThe number of ambulatory patients seeking treatment for skin and skin structure infections (SSSI) are increasing. The objective of this study is to determine recent trends in hospital admissions and healthcare resource utilization and identify covariates associated with hospital costs and mortality for hospitalized adult patients with a primary SSSI diagnosis in the United States.MethodsWe performed a retrospective cross-sectional analysis (years 2005–2011) of data from the US Healthcare Cost and Utilization Project National Inpatient Sample. Recent trends, patient characteristics, and healthcare resource utilization for patients hospitalized with a primary SSSI diagnosis were evaluated. Descriptive and bivariate analyses were conducted to assess patient and hospital characteristics.ResultsA total of 1.8% of hospital admissions for the years 2005 through 2011 were for adult patients with a SSSI primary diagnosis. SSSI-related hospital admissions significantly changed during the study period (P < .001 for trend) ranging from 1.6% (in 2005) to 2.0% (in 2011). Mean hospital length of stay (LOS) decreased from 5.4 days in the year 2005 to 5.0 days in the year 2011 (overall change, P < .001) with no change in hospital costs. Patients with postoperative wound infections had the longest hospital stays (adjusted mean, 5.81 days; 95% confidence interval (CI), 5.80–5.83) and highest total costs (adjusted mean, $9388; 95% CI, $9366-$9410). Year of hospital admission was strongly associated with mortality; infection type, all patient refined diagnosis related group severity of illness level, and LOS were strongly associated with hospital costs.ConclusionsHospital admissions for adult patients in the United States with a SSSI primary diagnosis continue to increase. Decreasing hospital inpatient LOS and mortality rate may be due to improved early treatment. Future research should focus on identifying alternative treatment processes for patients with SSSI that could shift management from inpatient to outpatient treatment settings.

Highlights

  • The US Food and Drug Administration (FDA) coined the term acute bacterial skin and skin structure infections (ABSSSIs) in a guidance document for industry released in the year 2013. [1] The FDA defines ABSSSIs as lesions with a minimum surface area of approximately 75 cm2 and includes cellulitis/erysipelas, wound infections, and major cutaneous abscesses

  • SSSI-related hospital admissions significantly changed during the study period (P < .001 for trend) ranging from 1.6% to 2.0%

  • Decreasing hospital inpatient length of stay (LOS) and mortality rate may be due to improved early treatment

Read more

Summary

Introduction

The US Food and Drug Administration (FDA) coined the term acute bacterial skin and skin structure infections (ABSSSIs) in a guidance document for industry released in the year 2013. [1] The FDA defines ABSSSIs as lesions with a minimum surface area of approximately 75 cm and includes cellulitis/erysipelas, wound infections, and major cutaneous abscesses. The US Food and Drug Administration (FDA) coined the term acute bacterial skin and skin structure infections (ABSSSIs) in a guidance document for industry released in the year 2013. [1] The FDA defines ABSSSIs as lesions with a minimum surface area of approximately 75 cm and includes cellulitis/erysipelas, wound infections, and major cutaneous abscesses. The number of ambulatory patients seeking treatment for skin and skin structure infections (SSSI) are increasing.

Objectives
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.